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Abstract
In this report we briefly describe a patient with a dual chamber implantable cardioverter
defibrillator in the context of severe ischemic cardiomyopathy who developed persistent atrial
fibrillation. After appropriate anticoagulation and under mild sedation the patient was successfully
cardioverted to sinus rhythm after a programmed ventricular synchronized defibrillation using his
defibrillator. Programmed internal cardioversion of persistent atrial fibrillation in patients who have
an implantable cardioverter defibillator without atrial defibrillation capabilities could be an effective
and safe therapeutic option. Unlike external electrical cardioversion, thi s  s t r a t e g y  d o e s  n o t
interfere with the implantable cardioverter defibrillator, is more effective, and obviates the need of
general anesthesia. This strategy should be further evaluated in clinical trials.
Case report
A 73-year-old Caucasian man presented to the outpatient
clinic for evaluation of a recent episode of implantable
cardioverter defibrillator (ICD) shock therapy. He had
been implanted a dual chamber ICD (Model 1871, Vital-
ity DR, Guidant Corp.) for secondary prevention due to
resuscitated sustained ventricular tachycardia, not related
to a correctable cause, in the context of severe ischemic
cardiomyopathy. His past medical history was significant
for coronary artery disease (old myocardial infarction and
coronary artery bypass surgery), hypertension, diabetes
mellitus, and hyperlipidemia. The patient's medications
included metoprolol, ramipril, glimepiride, aspirin, and
simvastatin.
Interrogation of the stored events revealed that the recent
episode of shock was an appropriate defibrillation (21 J
biphasic shock) of ventricular arrhythmia (cycle length
330 ms) that classified into the VF zone. However, electro-
cardiographic examination and evaluation of the current
electrograms revealed the presence of atrial fibrillation
(AF) with a ventricular response of 84 beats/min (Figures
1, 2). The duration of AF was unknown while no event of
inappropriate shock attributed to AF was detected. All
hematological and biochemical studies including thyroid
function tests were within normal limits. An echocardio-
graphic study showed left ventricular (LV) dilatation with
global systolic dysfunction (ejection fraction: 0.20) and
evidence of increased filling pressures. The left atrial (LA)
anteroposterior diameter was 41 mm and the LA diastolic
volume 36 ml.
Taking into account the severely impaired left ventricular
systolic function as well as the absence of LA enlargement
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we decided to follow a rhythm control strategy. Therefore,
the patient was placed on appropriate anticoagulation
therapy for 4 weeks and scheduled for cardioversion. He
was admitted to the Coronary Care Unit and placed to
electrocardiographic, non-invasive hemodynamic, and
respiratory monitoring. After performing mild sedation
with midazolam, the patient's ICD was externally pro-
grammed to deliver an R-wave synchronized ventricular
biphasic shock of 31 J. The cardioversion was successful
with immediate restoration of sinus rhythm (Figure 3).
Subsequently, the patient was placed on amiodarone for
sinus rhythm maintenance while continued receiving b-
blocker therapy and anticoagulation. His recovery was
rapid and uneventful and discharged 6 hours later. After a
10-month follow-up period, the patient remains on sinus
rhythm and on good clinical condition. His LV ejection
fraction has been improved to 0.28 while the LV filling
pressures are normal. Interestingly, the patient does not
remember any shock or associated pain with respect to the
AF cardioversion.
Discussion
ICD implantation rates are growing rapidly both for pri-
mary and secondary prevention of sudden cardiac death
[1,2]. Given that ICD implantation is increasingly applied
in patients with advanced structural heart disease, the
prevalence of AF in ICD patients has been increased. Of
note, a significant proportion of ICD patients have a his-
tory of AF or will develop AF after implantation while par-
oxysmal or persistent AF in ICD patients has been
associated with subsequent appropriate therapy for ven-
tricular arrhythmias [3-5]. Despite technological advances
and sophisticated algorithms for improved discrimina-
tion between supraventricular and ventricular arrhyth-
12-lead electrocardiogram of the patient at presentation Figure 1
12-lead electrocardiogram of the patient at presentation.Cases Journal 2008, 1:152 http://www.casesjournal.com/content/1/1/152
Page 3 of 4
(page number not for citation purposes)
mias, inappropriate shocks represent a continuous
problem in ICD patients and AF is the most frequent
cause [6].
On the other hand, it is well-known that AF adversely
affects myocardial performance, exercise tolerance, and
quality of life, especially in patients with heart failure [7].
Moreover, AF per se is associated with increased morbidity
and mortality mainly due to embolic events [7]. During
the past few years ICDs that offer atrial defribrillator ther-
apy have been developed. However, these devices have
not gained wide acceptance [8]. The main reason for this
fact is that the conscious patients experience pain during
the atrial defibrillation shock. Even low energy shocks in
the order of 1 J are uncomfortable for the patients leading
to a significant impairment of the quality of life [8]. In
other words, their shocks are considered as painful as the
standard ICD ventricular defibrillations [8].
Synchronized electrical cardioversion is the preferable
choice of therapy for persistent AF while the pharmaco-
logical cardioversion has limited role in this form of AF
[9,10]. In specific, internal defibrillation shocks are pref-
erable and more effective compared to external shocks in
ICD patients [10]. Low energy delivered by the internal
defibrillation lessens the risk for interference with the ICD
programming as well as the risk for endocardial damage
whereas the need for general anesthesia is obviated.
Conclusion
Our case demonstrates that programmed ventricular ICD
discharge under mild sedation could be an interesting
option for quick, effective, and safe cardioversion of per-
Interrogation of the ICD before cardioversion – Electrogram strip showing atrial fibrillation Figure 2
Interrogation of the ICD before cardioversion – Electrogram strip showing atrial fibrillation.
Electrogram strip after cardioversion of atrial fibrillation Figure 3
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sistent AF. Taking into account the aforementioned con-
siderations, this practice may have a particular role in
patients with advanced heart failure. Undoubtedly, this
strategy should be further evaluated in clinical trials.
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